CUDC-907 boosts temozolomide response in glioblastoma by dual PI3K/HDAC inhibition
Glioblastoma (GBM) is an aggressive brain cancer that frequently returns after treatment, largely due to acquired resistance to standard chemotherapy ...
Glioblastoma (GBM) is an aggressive brain cancer that frequently returns after treatment, largely due to acquired resistance to standard chemotherapy ...
In a groundbreaking leap forward for cancer treatment technology, scientists in China have engineered magnetically controlled microrobots derived from diatoms—single-celled ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine